Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

Summary

KI1001(Circadin®, Prolonged release tablet which contains melatonin) has showed its efficacy to improve sleep quality in over 55 years old primary insomnia patients. This is a bridging study to investigate the efficacy and safety of KI1001(Circadin®) in Korean patients.

Timeline

Start

2011-03

Primary completion

2012-03

Completion

2012-03

Drugs

Indications